Google Translate Disclaimer

A number of pages on the Government of Saskatchewan`s web site have been professionally translated in French. These translations are identified by a yellow text box that resembles the link below and can be found in the right hand rail of the page. The home page for French-language content on this site can be found here:

Renseignements en Français

Where an official translation is not available, Google™ Translate can be used. Google™ Translate is a free online language translation service that can translate text and web pages into different languages. Translations are made available to increase access to Government of Saskatchewan content for populations whose first language is not English.

The results of software-based translation do not approach the fluency of a native speaker or possess the skill of a professional translator. The translation should not be considered exact, and may include incorrect or offensive language Government of Saskatchewan does not warrant the accuracy, reliability or timeliness of any information translated by this system. Some files or items cannot be translated, including graphs, photos, and other file formats such as portable document formats (PDFs).

Any person or entities that rely on information obtained from the system does so at his or her own risk. Government of Saskatchewan is not responsible for any damage or issues that may possibly result from using translated website content. If you have any questions about Google™ Translate, please visit: Google™ Translate FAQs.

Drug Pricing Initiative to Provide Millions in Savings for Saskatchewan

Released on January 29, 2018

Saskatchewan residents will soon benefit from lower prices on generic drugs. A new national generic drug initiative will result in $6 million in savings in the first year and up to $50 million in savings over the next five years for the Saskatchewan Drug Plan.

Savings for patients and employers are expected to match or exceed those achieved by the provincial government. 

Through the pan-Canadian Pharmaceutical Alliance (pCPA), provinces and territories have developed a new initiative with the Canadian Generic Pharmaceutical Association (CGPA) to significantly reduce the price of some of Canada’s most commonly prescribed generic drugs.

“We know medicine is expensive, and our government is committed to providing Saskatchewan residents with the best value for the important drugs they rely on,” Health Minister Jim Reiter said.  “In addition to benefitting the public, it benefits the province as well.  The savings we realize will help our public drug plan provide coverage for new and innovative drugs, and increase the plan’s sustainability.”

As of April 1, 2018, the prices of nearly 70 generic drugs will be reduced by 25 to 40 per cent, resulting in overall discounts of up to 90 per cent off the price of their brand-name equivalents. Generic drugs included in the initiative are used to treat a variety of conditions, including high blood pressure, high cholesterol and depression. 

The initiative also includes a commitment from generic drug manufacturers to continue bringing new generic drugs to the Canadian market and ensure a stable supply of generic drugs across the country. 

Saskatchewan served as a co-lead, along with British Columbia and Ontario, in developing this initiative. For more information about the generic drugs covered by this initiative, visit http://formulary.drugplan.ehealthsask.ca/PanCanadian.aspx

-30-

For more information, contact:

Shirley Xie
Health
Regina
Phone: 306-787-4083
Email: shirley.xie@health.gov.sk.ca

We need your feedback to improve saskatchewan.ca. Help us improve